Cardiac effects of antiparkinson drugs, local anesthetics, and tranquilizers.
D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology*; D003331:Coronary Vessels; D004357:Drug Synergism; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D010640:Phenothiazines / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D014282:Trihexyphenidyl / Q000494:pharmacology; D014326:Tropanes / Q000494:pharmacology
D010276:Parasympatholytics; D010640:Phenothiazines; D014326:Tropanes; D014282:Trihexyphenidyl; D008012:Lidocaine; D011188:Potassium; D002746:Chlorpromazine